Please login to the form below

Not currently logged in
Email:
Password:

company strategy

This page shows the latest company strategy news and features for those working in and with pharma, biotech and healthcare.

Pfizer's basic instincts

Pfizer's basic instincts

Now most of Pfizer has always been what we’d call research based, so this signals an intensification of the company’s existing strategy. ... He made two points that added to a third, basic instinct about strategy.

Latest news

  • AstraZeneca takes home Company of the Year award at PMEA 2020 AstraZeneca takes home Company of the Year award at PMEA 2020

    AstraZeneca also won awards in theand Excellence in Capability Development, reflecting a very successful evening for the company! ... The company provided a strong articulation of strategy delivered with energy and enthusiasm by a very senior team,

  • Biogen joins COVID-19 efforts with $10m support fund Biogen joins COVID-19 efforts with $10m support fund

    According to a statement released by the company yesterday, the funds will be used to address ‘immediate critical needs’, with the majority of the donations to be made in support of ... The move follows an outbreak at the Massachusetts-based biotech

  • FDA approves Sanofi’s key cancer drug Sarclisa for myeloma FDA approves Sanofi’s key cancer drug Sarclisa for myeloma

    Importantly, the approval of Sarclisa aligns with Sanofi’s narrower focus – last year, Hudson revealed a new strategy for the company, shedding research in its troubled diabetes and cardiovascular franchises to ... According to the company’s

  • The digital shift in pharma marketing The digital shift in pharma marketing

    One of the panelists who leads omnichannel and data strategy for a large pharma company strongly recommended grabbing every opportunity to know your customer, gather data from various touchpoints, and then ... Digital inspiration for pharma on mobile,

  • Newly-listed BioNTech buys Neon to boost cell therapy assets Newly-listed BioNTech buys Neon to boost cell therapy assets

    share the company secured for shares in its IPO less than two years ago. ... In a statement, BioNTech said the deal would give it a US hub for research and clinical development, with Neon operating as a subsidiary company.

More from news
Approximately 51 fully matching, plus 141 partially matching documents found.

Latest Intelligence

  • Working in true partnership in a time of change Working in true partnership in a time of change

    The starting point. The first priority is to re-map customers and influencers across your entire geography and organisational structures and to re-evaluate your company’s strategy around growth and ... Combine this with your existing knowledge of

  • Gut instincts lead Takeda to GI pipeline success Gut instincts lead Takeda to GI pipeline success

    Takeda’s Asit Parikh talks about a game changer for IBD patients and the company’s long-term strategy for gene and cell therapy. ... that focused the company’s R&D strategy on cutting-edge, innovative approaches in GI, oncology and the central

  • Why pharma should invest in the education of doctors Why pharma should invest in the education of doctors

    Thinking of sales in this way creates a shift to a longer-term strategy. ... Developing a content strategy. So, how does the modern pharma company go about addressing the challenges behind educational content?

  • Can marketing change the world? Can marketing change the world?

    These are metrics where health brands ought to score highly. However, only one healthcare company (J&J) makes the top 30 meaningful brands of 2019, with tech disruptors making up four ... Summit. “What it unlocked was actually a totally new strategy

  • As the opioid crisis grabs the headlines, the search for safe treatments continues As the opioid crisis grabs the headlines, the search for safe treatments continues

    The company’s mantra ‘Addiction is a treatable chronic condition, not a moral failure’ is sustaining its R&D work and Gilles Picard (pictured above), its head of global strategy and ... European operations, said the company is close to new

More from intelligence
Approximately 4 fully matching, plus 38 partially matching documents found.

Latest appointments

  • Ashfield Advisory adds Mary-Kate McGarry and Emer Jameson to senior leadership team Ashfield Advisory adds Mary-Kate McGarry and Emer Jameson to senior leadership team

    McGarry has been appointed as vice president of strategy, while Jameson joins as vice president of HR. ... At Ashfield Advisory, she will be responsible for driving all aspects of the company’s strategy and will work closely with the mergers and

  • Ex-BMS exec jumps to Gilead to lead research group Ex-BMS exec jumps to Gilead to lead research group

    At BMS, Quigley held responsibility for setting the strategy for the company’s oncology discovery portfolio and business development activities. ... Higgins (pictured right) joined Gilead in 2010 to lead an expansion of the company’s biology

  • New hires at bluebird bio, BioNTech and Provention Bio New hires at bluebird bio, BioNTech and Provention Bio

    She will replace Andrew Obenshain, who has now joined the company’s global leadership team in Boston, US. ... In his role as CCO at Provention, Hoitt will be responsible for the development and execution of the company’s global commercial strategy

  • New hires at Ferring, Flexion and Immunocore New hires at Ferring, Flexion and Immunocore

    Flexion Therapeutics names chief strategy officer. Biopharmaceutical company Flexion Therapeutics has named Christina Willwerth as its chief strategy officer. ... Willwerth joined Flexion back in 2009 and most recently served as the company’s senior

  • Chameleon reveals new leadership line-up Chameleon reveals new leadership line-up

    He will report into Matt D’Auria, chief executive of Chameleon’s parent company Healthcare Consultancy Group. ... The company’s US executive vice president of commercial development, Guy Slatcher now moves into the role of president, Chameleon US.

More from appointments
Approximately 0 fully matching, plus 65 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 17 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

Numbers, navigation, and narratives: digital storytelling in medical communications
Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...
Is this common data mistake killing your digital patient recruitment?
Without realising, you could be falling into the trap of using social data — insights into recent, relevant trends and topics — to inspire your content. Hold up. That sounds...
Dr Henry Skinner
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
By Henry Skinner, Chief Executive Officer of the AMR Action Fund...